Search results for "T-1"

showing 10 items of 69 documents

MRI findings and genotype analysis in patients with childhood onset growth hormone deficiency--correlation with severity of hypopituitarism.

2007

Aim: To evaluate the relationship between pituitary size, PIT1 and PROP1 genotype, and the severity of childhood onset growth hormone deficiency (coGHD). Patients: Forty-four patients with coGHD (34 M; 9.7 ± 4.1 years): severe isolated (SI) GHD (n = 14); partial isolated (PI) GHD (n = 13); multiple pituitary hormone deficiencies (MPHD) (n=17). Results: Pituitary abnormalities were found in 7/14 patients with SIGHD (50%), 16/17 patients with MPHD (94.1%), and no patient with PIGHD. Mean pituitary height (PHT SDS) was significantly lower in MPHD than in SIGHD and PIGHD. Pituitary height SDS and pituitary volume (PV) SDS correlated with IGF-I SDS and stimulated GH peaks in the SIGHD and MPHD g…

Malemedicine.medical_specialtyAdolescentGenotypeEndocrinology Diabetes and MetabolismGenotype AnalysisHypopituitarismHypopituitarismGrowth hormone deficiencyCorrelationEndocrinologyInternal medicineAge Determination by SkeletonGenotypemedicineHumansIn patientAge of OnsetChildDwarfism PituitaryRetrospective StudiesHomeodomain Proteinsbusiness.industrymedicine.diseaseMagnetic Resonance ImagingBody HeightEndocrinologyChild PreschoolPituitary GlandPediatrics Perinatology and Child HealthPituitary hormonesDisease ProgressionFemalebusinessTranscription Factor Pit-1Mri findingsJournal of pediatric endocrinologymetabolism : JPEM
researchProduct

Acetylcholine leads to signal transducer and activator of transcription 1 (STAT-1) mediated oxidative/nitrosative stress in human bronchial epithelia…

2013

AbstractThe induction of nitric oxide synthase (iNOS) expression via the signal transducer and activator of transcription 1 (STAT-1) is involved in the mechanism of oxidative/nitrosative stress. We investigated whether acetylcholine (ACh) generates oxidative/nitrosative stress in bronchial epithelial cells during airway inflammation of COPD and evaluated the effects of Tiotropium, a once-daily antimuscarinic drug, and Olodaterol, a long-acting β2-agonist on these mechanisms. Human bronchial epithelial cells (16-HBE) were stimulated (4h, 37°C) with induced sputum supernatants (ISSs) from healthy controls (HC) (n=10), healthy smokers (HS) (n=10) or COPD patients (n=10), as well as with ACh (f…

Malemedicine.medical_specialtyBlotting WesternNitric Oxide Synthase Type IIBronchiOxidative phosphorylationCholinergic AgonistsFlow cytometrychemistry.chemical_compoundPulmonary Disease Chronic ObstructiveWestern blotInternal medicinemedicineHumansRNA Small InterferingMolecular BiologyCells Culturedchemistry.chemical_classificationReactive oxygen speciesbiologymedicine.diagnostic_testNitrotyrosineEpithelial CellsMiddle AgedAcetylcholinerespiratory tract diseasesEpithelial cellNitric oxide synthaseOxidative StressEndocrinologySTAT1 Transcription FactorchemistrySTAT proteinbiology.proteinOxidative/nitrosative stressTyrosineMolecular MedicineSTAT-1FemaleReactive Oxygen SpeciesAcetylcholinemedicine.drugBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
researchProduct

Structural and CO [sub] 2 capture properties of ethylenediamine-modified HKUST-1 metal-organic framework

2020

The high structural and compositional flexibility of metal–organic frameworks (MOFs) shows their great potential for CO2 capture and utilization in accordance with the environmental guidelines of low-carbon technology developments. HKUST-1 as one of the most intensively studied representatives of MOFs for such purposes excels because of its simplicity of production and high ability to tune its intrinsic properties by various functionalization processes. In the present work, ethylenediamine functionalization was performed for the first time in order to thoroughly investigate the amine sorption sites’ impact on the CO2 capture performance of HKUST-1. The placement of ethylenediamine moieties …

Materials scienceEthylenediaminemodifikacije010402 general chemistry01 natural sciencesmaterialschemistry.chemical_compoundAdsorptionudc:620.1/.2Specific surface areaGeneral Materials ScienceFourier transform infrared spectroscopyfunkcionalizacijamodificationCO2 Ethylenediamine HKUST-1 Metal-Organic FrameworkExtended X-ray absorption fine structure010405 organic chemistrySorptionGeneral ChemistryCondensed Matter Physics0104 chemical scienceschemistryChemical engineeringadsorptionadsorbcijamaterialiSurface modificationfunctionalizationMetal-organic frameworkextended X-ray absorption fine structuremof
researchProduct

The Pvt-1 oncogene is a target of Myc and its expression is deregulated in neuroblastoma cells

2003

NeuroblastomaPvt-1MycOncogene
researchProduct

The NEXT path to neutrino inverse hierarchy

2018

De todas las partículas que componen el universo, quizás la más común de ellas sea también la más misteriosa, el neutrino. Ahora mismo miles de millones de estas partículas nos atraviesan sin percibirlo, y detectar una sola de ellas necesita de enormes detectores enterrados a gran profundidad. Postuladas por primera vez por Wolfgang Pauli en 1930, fueron bautizadas en 1934 como ”pequeños neutrones” por Enrico Fermi, aludiendo a dos de sus principales características: su pequeña masa y su ausencia de carga eléctrica. A mediados de los años 70, los neutrinos fueron incluidos en el Modelo Estándar bajo las premisas de: carecer de masa y carga eléctrica, experimentar únicamente la fuerza nuclea…

Neutrino mass:FÍSICA [UNESCO]NeutrinoUNESCO::FÍSICACanfrancNEXTNEXT-100Double beta decayMajorana
researchProduct

Zvaigžņotā Debess: 2004/05, Ziema

2004

Contents: Ņ.Ozoliņa. Earthquakes in Latvia ; I.Daube. Space Craft “Ranger-7” ; M. Gailis. Moon Investigation in Riga ; J.Tambergs. Problems of Dialogue between Quantum Mechanics and Theology (concluded) ; Z Alksne, A.Alksnis. Ultra-Cool Dwarf Pair Weighed ; A.Balklavs. Successful Hunt of Protostars ; A.Balklavs. Silhouette of a Black Hole ; A.Balklavs. A Distant Giant Quasar ; A.Balklavs. Cosmic Objects in Captivating Photos – 3 ; J.Freimanis. Extragalactic Planetary Nebulae ; J.Jaunbergs. Cassini Enters the Saturnian System ; D.Krieviņš. Space Launchers of Early XXI Century. The Commonwealth of Independent States (CIS) ; J.Bārzdiņš. Professor Rusins-Martins Freivalds on the Path of Science…

Novembra kāvi Baltijas debesīsGalēji auksto punduru sistēma 2MASSW J0746425+2000321Herbiga-Haro objekti HH-30 HH-34 HH-47Krustvārdu mīklaLīgatnes meteorīts – hipotēzeProtozvaigznesPlanetārie miglāji – NGC 2392 (Eskimosa miglājs) NGC 6369 (Spociņa miglājs)Starptautiskā komandu olimpiāde “Baltijas ceļš – 2003” – uzdevumu atrisinājumiRisina lasītājsNASA Genesis – Saules vēja paraugiLU profesors Rūsiņš-Mārtiņš FreivaldsZemestrīces LatvijāBlumbaha spoguļteleskops BSTPirmās galaktikasCassini misija Saturna sistēmāJakobs Juliuss ZeibotsJupitera pavadoņa Jo putekļiRīgas topogrāfiskā uzmērīšanaSavādnieki eksaktajās zinātnēs – Dž.Maksvels O.Sevisaids H.Hercs V.Pauli V.Heizenbergs B.Mandelbrots A.Vītols J.Vītols G.Šipovs A.AkimovsMeteorītu panspermijaPlanetārie miglāji N52 N66 N192 SMP93 Lielajā Magelāna MākonīVenēras un Merkura aizklāšanāsKosmiskie transportlīdzekļi – NVSAstronomiskās parādības - 2005Melnais caurums – siluetsKalenaisa – “Hebridu Stounhendža”Planētu redzamības kompleksā diagramma 2005Zvaigžņu lietus novembrīESA Smart-1Astronomiskās parādības - 2004Kvantu mehānika un teoloģijaMilzu kvazārs J1432+158Londonas universitātes Berkbeka koledža
researchProduct

Hypernuclear spectroscopy of products from Li-6 projectiles on a carbon target at 2 A GeV

2013

WOS: 000322848900009

Nuclear reaction(Li-6E=2 GeV/nucleonNuclear and High Energy PhysicsMaximum likelihoodWEAK DECAYFOS: Physical sciencesLIFETIMET-1/2. Compared with other datadeduced Lambda massC-12(LAMBDA)H-4)T-1/2measured Lambda H-3H-4 Lambda-hypernuclei invariant mass distribution T-1/2measured LambdaInvariant massNuclear Experiment (nucl-ex)LIGHT HYPERFRAGMENTSSpectroscopyNuclear ExperimentX)PhysicsH-4 Lambda-hypernuclei invariant mass distributionH-3ProjectileSignificance valueslifetime measurementdeduced Lambda mass H-3H-4 Lambda-hypernuclei mass T-1/2. Compared with other data lifetime measurementNUCLEAR REACTIONS C(Li-6Decay timeLAMBDA-HYPERNUCLEIAtomic physicst)NUCLEAR REACTIONS C(Li-6 X) (Li-6 t) (Li-6 H-4) E=2 GeV/nucleonH-4 Lambda-hypernuclei massHypertritonRELATIVISTIC HYPERNUCLEINuclear Physics A
researchProduct

TRIPLET SCHEDULE OF WEEKLY 5-FLUOROURACIL AND ALTERNATING IRINOTECAN OR OXALIPLATIN IN ADVANCED COLORECTAL CANCER: A DOSE-FINDING AND PHASE II STUDY.

2010

A weekly administration of alternating irinotecan or oxaliplatin associated to 5-Fluorouracil in advanced colorectal cancer was planned in order to evaluate a new schedule maintaining dose intensities of each drug as in double combinations and tolerability of the triplet association. The following weekly schedule was administered: irinotecan, days 1 and 15; oxaliplatin, days 8 and 22; 5-fluorouracil (5-FU) over 12-h (from 10:00 p.m. to 10:00 a.m.) timed flat infusion, days 1-2, 8-9, 15-16 and 22-23, every 4 weeks. Dose- finding and phase II study were planned. Thirteen patients were enrolled in the dose-finding study and 23 in the phase II study. The recommended doses of our study are: irin…

OncologyAdultMaleCancer Researchmedicine.medical_specialtyLung NeoplasmsMaximum Tolerated DoseOrganoplatinum CompoundsSettore MED/06 - Oncologia Medica5-FluorouracilPhases of clinical researchIrinotecanGastroenterologyInternal medicineCPT-11Antineoplastic Combined Chemotherapy ProtocolsmedicineHumansAdvanced colorectal cancerAgedDose-Response Relationship Drugbusiness.industryLiver NeoplasmsGeneral MedicineMiddle Agedmedicine.diseaseOxaliplatinIrinotecanOxaliplatinSurvival RateRegimenTreatment OutcomeOncologyTolerabilityFluorouracilLymphatic MetastasisToxicityl-OHPCamptothecinFemaleFluorouracilbusinessColorectal NeoplasmsFebrile neutropeniamedicine.drug
researchProduct

Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective …

2017

Abstract Introduction:Even in the era of novel targeted therapies for the treatment of Chronic Lymphocytic Leukemia (CLL) patients, such as BTK, PI3K and BCL2 inhibitors, allogeneic hematopoietic stem cell transplantations (alloHCT) will remain an important treatment option for a subset of patients with very high risk CLL. The current study focused on the impact of center and procedure-related factors on outcomes after alloHCT, taking into account the impact of patient- and disease-related risk factors. Patients and Methods:Data of 684 CLL patients who received a first alloHCT between 2000 and 2011 were analyzed. Their data were collected as part of the EBMT CLL Data Quality Initiative. Out…

OncologyMaleTransplantation ConditioningCancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2]Chronic lymphocytic leukemiaMedizinQUALITY MANAGEMENT-SYSTEMKaplan-Meier Estimaterisk factor analysisGUIDELINESBiochemistryallogeneic stem cell transplantation; centre effects; chronic lymphocytic leukaemia; frailties; risk factor analysiscentre effectsTransplantation Conditioning / methods0302 clinical medicineRecurrenceRisk Factorsallogeneic stem cell transplantationLeukemia Lymphocytic Chronic B-Cell / mortalityRegistriesDelivery of Health Care / statistics & numerical dataIBRUTINIBddc:6160303 health sciencesALEMTUZUMABHazard ratioHematopoietic Stem Cell TransplantationProfessional PracticeHematologyMiddle Aged3. Good healthEurope030220 oncology & carcinogenesisABT-199CohortSURVIVALAlemtuzumabFemaleEurope / epidemiologymedicine.drugAdultmedicine.medical_specialtyAllogeneic transplantationImmunologyLower riskDIAGNOSISSettore MED/01 - Statistica Medica03 medical and health sciencesLeukemia Lymphocytic Chronic B-Cell / therapyHematopoietic Stem Cell Transplantation / methodsInternal medicinemedicineHumansKarnofsky Performance Status030304 developmental biologyAgedRetrospective Studiesbusiness.industryProportional hazards modelCHRONIC LYMPHOCYTIC-LEUKEMIARetrospective cohort studySTEM-CELL TRANSPLANTATIONCell Biologymedicine.diseaseLeukemia Lymphocytic Chronic B-CellConfidence intervalSurgeryProfessional Practice / statistics & numerical dataTransplantationbusinessDelivery of Health Carefrailtieschronic lymphocytic leukaemia030215 immunologyRESPONSES
researchProduct

The Next White (NEW) detector

2018

[EN] Conceived to host 5 kg of xenón at a pressure of 15 bar in the ¿ducial volume,the NEXTWhite (NEW)apparatus is currently the largest high pressure xenon gas TPC using electroluminescent ampli¿cation in the world. It is also a 1:2 scale model of the NEXT-100 detector scheduled to start searching for ßß0¿ decays in 136Xe in 2019. Both detectors measure the energy of the event using a plane of photomultipliers located behind a transparent cathode. They can also reconstruct the trajectories of charged tracks in the dense gas of the TPC with the help of a plane of silicon photomultipliers located behind the anode. A sophisticated gas system, common to both detectors, allows the high gas puri…

Physics - Instrumentation and DetectorsXenon010308 nuclear & particles physicsEuropean researchLibrary scienceFOS: Physical sciencesInstrumentation and Detectors (physics.ins-det)7. Clean energy01 natural sciencesHigh-pressure xenon chambersTECNOLOGIA ELECTRONICATime Projection Chamber (TPC)Political science0103 physical sciencesmedia_common.cataloged_instanceEuropean unionNeutrinoless double beta decay010306 general physicsInstrumentationMathematical Physicsmedia_commonNEXT-100 experiment
researchProduct